-
Product Insights
Keratoconjunctivitis Sicca (Dry Eye): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, 2026" provides an overview of Keratoconjunctivitis Sicca (Dry Eye) Clinical trials scenario. This report provides top line data relating to the clinical trials on Keratoconjunctivitis Sicca (Dry Eye). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Diabetic Foot Ulcers: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Diabetic Foot Ulcers - Global Clinical Trials Review, 2026" provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Ewing Sarcoma: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2026" provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cerebral Palsy: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Cerebral Palsy - Global Clinical Trials Review, 2026" provides an overview of Cerebral Palsy Clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Palsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Tuberous Sclerosis: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Tuberous Sclerosis - Global Clinical Trials Review, 2026" provides an overview of Tuberous Sclerosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberous Sclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Asthma: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Asthma - Global Clinical Trials Review, 2026" provides an overview of Asthma Clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Rheumatic Disorders: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Rheumatic Disorders - Global Clinical Trials Review, 2026" provides an overview of Rheumatic Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Rheumatic Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Thematic Analysis
The Future of Pharma​ - Looking Ahead to 2026
Understand Where the Pharmaceutical Industry Is Heading The pharmaceutical industry is entering a phase of rapid transformation, driven by shifts in drug development, regulation, and market dynamics. This report provides a clear, high-level view of both near-term and long-term changes shaping the industry, helping you understand how these shifts impact strategy, investment, and innovation. It brings together regulatory, clinical, and market-based analysis to highlight the major forces influencing the future of pharma. Report Value Proposition – Why This Matters for...
-
Sector Analysis
Venous Thromboembolism Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034
According to GlobalData estimates, 2024 base year sales within the VTE market are approximately $3.93 billion across 7MM and will grow at a compound annual growth rate (CAGR) of 2.6% to reach $5.10 billion by the end of the forecast period. VTE is a disease that includes a myriad of life-threatening disorders ranging from PE to DVT. The condition is relatively prevalent and is associated with long-term mortality and morbidity
-
Track & Monitor
Venture Capital Investment Trends in Pharma - Q1 2026
This report analyzes the venture capital (VC) investment activity in Q1 2026 in the Pharma sector.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.